Rallybio Corp
RLYB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739410
No open-market purchases or sales by Rallybio Corp insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $65.0M in total; Viking Global Investors is the only superinvestor holding it.
Superinvestors holding RLYB, Q2 2026
1 superinvestor reports holding Rallybio Corp on Form 13F, worth $8.39M in total. Weight is Rallybio Corp's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Viking Global InvestorsAndreas Halvorsen | <0.1% | 524,347 | $8.39M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of RLYB each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2022
1 superinvestor holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q3 2021
2 superinvestors holding at quarter end